Home » Feature » Page 11

Feature

Featured posts

NDASA Announces International Day addition to its 2025 Conference & Trade Show

Welcome international attendees! The National Drug and Alcohol Screening Association (NDASA,) in partnership with the International Forum for Drug & Alcohol Testing (IFDAT), is proud to add International Day to its annual Conference & Trade Show in...

30 under 30: Help NDASA identify and celebrate rising stars in the industry

Submit an outstanding young person in the drug and alcohol testing industry In 2025, NDASA will recognize 30 incredible young professionals in our industry aged 30 and under who represent the future of safe workplaces, families and communities. Submissions meeting the...

NDASA releases comments in support of the Department of Transportation’s recent proposal to allow electronic recordkeeping for regulated drug and alcohol testing

If you have not yet submitted your comments to ODAPC's Notice of Proposed Rulemaking to allow electronic record creation, signatures and storage under 49 CFR Part 40, please consider commenting by DECEMBER 16, 2024. NDASA's submitted comments are included below....

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

Buyer beware: CBD, THC and drug testing

Buyer beware: CBD, THC and drug testing

Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...

The epidemic within the pandemic

The epidemic within the pandemic

Long before the coronavirus arrived in the United States, this country was already struggling with another health crisis: the opioid epidemic. As these two epidemics are colliding, experts fear that people vulnerable to opioid use disorders and those who employ them...